Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The "CD22 Targeted Therapies Market, Approved Drug Sales, Technology Platforms & Clinical Trials Insight 2026" report has been added to ...
-
Avance Clinical will meet biotech sponsors at Biotech Showcase 2026 in San Francisco, highlighting the launch of the new Early Phase Center of Excellence.
-
SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing...
-
PharmAla inks contract with Ostfold Hospital Trust in Oslo to supply clinical trial in exchange for both cash and a data license
-
Science 37 Named Finalist for 2026 SCOPE Participant Engagement and Site Innovation Awards.
-
Avance Clinical Strengthens Global Oncology Offering with Acquisition of U.S.-Based LumaBridge and Establishes New Oncology Center of Excellence.
-
Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook 2030" report has been added to ResearchAndMarkets.com's offering.Report...
-
Hummingbird Bioscience today announced that the first patient has been dosed in a Phase I clinical trial of HMBD-501.
-
SAN FRANCISCO and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (“MapLight”) (Nasdaq: MPLT) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast...
-
Dublin, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The "AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects (May 11, 2026)" training has been added to ResearchAndMarkets.com's...